KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Capital Leases (2016 - 2018)

Medpace Holdings (MEDP) has disclosed Capital Leases for 4 consecutive years, with $24.5 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Capital Leases fell 7.96% year-over-year to $24.5 million, compared with a TTM value of $24.5 million through Dec 2018, down 7.96%, and an annual FY2018 reading of $24.5 million, down 7.96% over the prior year.
  • Capital Leases was $24.5 million for Q4 2018 at Medpace Holdings, down from $25.0 million in the prior quarter.
  • Across five years, Capital Leases topped out at $30.3 million in Q4 2015 and bottomed at $24.5 million in Q4 2018.
  • Average Capital Leases over 4 years is $27.1 million, with a median of $27.1 million recorded in 2017.
  • The sharpest move saw Capital Leases fell 5.77% in 2016, then dropped 7.96% in 2018.
  • Year by year, Capital Leases stood at $30.3 million in 2015, then fell by 5.77% to $28.5 million in 2016, then decreased by 6.75% to $26.6 million in 2017, then decreased by 7.96% to $24.5 million in 2018.
  • Business Quant data shows Capital Leases for MEDP at $24.5 million in Q4 2018, $25.0 million in Q3 2018, and $25.6 million in Q2 2018.